SDHB and metastatic neoplasm: The rate of metastatic disease varies greatly depending on the genetic background [1,2,9,28,35] with a low rate in cases of RET and SDHD mutations and in VHL disease, a rate of about 12% in NF-1, and up to 30–70% in cases of SDHB mutations [4,50,51].